اردو(Urdu) English(English) عربي(Arabic) پښتو(Pashto) سنڌي(Sindhi) বাংলা(Bengali) Türkçe(Turkish) Русский(Russian) हिन्दी(Hindi) 中国人(Chinese) Deutsch(German)
Sunday, July 21, 2024 22:31
Question of Palestine Eternal Wisdom: Iqbal Building Futures: Empowering Pakistan's Youth for Tomorrow Tourism: An Essential Element for Sustainable and Inclusive Growth Connecting Youth to Global Opportunities Algorithms: The Silent Architects of Warfare Pakistani Youth: The Driving Force for National Progress Investing in Future Generations: Pakistan Army Lost Voices: The Systematic Marginalization of Indian Muslims Parallel Struggles: Examining the Palestinian and Kashmiri Quests for Self-determination Emergence of BJP as a Hindutva Force The Fourth Industrial Revolution: Transforming Pakistan Building Sustainable Cities: Urban Search and Rescue Preparedness Simulation Exercise In the Pursuit of Happiness: Understanding Hedonia, Eudemonia, and Naikan COAS’ U.S. Visit: Strengthening Ties and Fostering Collaboration A Biological Marvel of Human Heart Educational Empowerment: FC Balochistan (North) Initiates Literacy Program for Soldiers Digital Pakistan Journey: Pioneering Towards a Connected Future Driving Digital Transformation: Pakistan CJCSC Calls on His Majesty King Abdullah II Ibn Al Hussain During His Visit to Jordan COAS' Peshawar Visit Highlights Security, Socioeconomic Development and National Unity Unity in Diversity: COAS Joins Christmas Celebrations with Christian Community in Rawalpindi Chief of the Naval Staff Attends Indian Ocean Naval Symposium in Bangkok Strengthening Bonds and Elevating Collaboration: Combat Commander Turkish Air Force Calls on Chief of the Air Staff Closing Ceremony of Multinational Special Forces Exercise Fajar Al Sharq-V Strengthens Counterterrorism Collaboration Off the Beaten Track: Exploring Jiwani's Coastal Marvels and Heritage Special Investment Facilitation Council: A Game Changer for the Economy of Pakistan Rising Stars: Pakistan’s Youth Shines Bright in 2023 Indian Supreme Court’s Decision and the International Law Challenges to Justice: The Indian Supreme Court’s Fallacy in IIOJK Belt and Road Initiative: Strengthening Global Ties with Unhindered Trade and Connectivity The Media Matrix: Unraveling How Technology Shapes Our Perception Decoding Human Interaction: The Comprehensive Guide to Reading Body Language The Magic of Moscow On the Same Wavelength: Suno FM's Impact on Community Empowerment, Diversity, and Social Progress in Pakistan The Journey of SAIL: A Beacon of Hope for Autism in Gilgit-Baltistan Pakistan National Youth Convention 2024: COAS Stresses Youth's Vital Role, Urges Unity, and National Strength Vice Foreign Minister of the People’s Republic of China Calls on COAS COAS Attends Inauguration Ceremony of the Second Chapter of NASTP Silicon PAF's Induction and Operationalization Ceremony Showcases Technological Advancements and Operational Excellence COAS Witnesses Firing of Different Air Defense Weapon Systems During Exercise Al-Bayza-III, 2024 COAS Visits POF Wah, Highlights Importance of Indigenous Defense Industry Exercise Sea Guard-24: Strengthening Maritime Security Al-Noor Special Children School and College Celebrates International Day of Persons with Disabilities 2023 in Multan Garrison Exercise BARRACUDA-XII: Strengthening Global Cooperation for Maritime Safety and Environmental Protection Pakistan-Qatar Joint Aerial Exercise "Zilzal-II" Held in Qatar March 23, 1940: Charting the Course for Pakistan's Future Peshawar’s Namak Mandi: A Gemstone Heaven Genocide in Palestine Rising Cities, Shrinking Spaces: Tackling Overpopulation and Urbanization in Pakistan Impact of Pakistan Resolution Day on National Identity Building Leaders: Jinnah and Iqbal's Timeless Wisdom for Today's Youth National Parks–Natural Assets India's New Playbook for Extraterritorial Assassination of Opponents The Legacy of Khan Brothers in Pakistan Armed Forces (Part II) Beyond the Battlefield: AIMH’s Quest for Military History Preservation The Siege of 634 A.D. (Part II) SIFC, From Vision to Reality (Part II) A New Dawn in Pakistan's Agriculture The Crowdsourcing Practices The Last Post: Eulogy of a Hero Securing Tomorrow’s Food: Sustainable Agriculture and Aquaculture in Pakistan The Saindak Copper-Gold Project: A Beacon of Pak-China Friendship and Prosperity Prime Minister of Pakistan, Prime Minister of Azad Jammu and Kashmir, and COAS Visit Muzaffarabad CJCSC Calls on Minister of Defense, KSA 7th International PATS Exercise-2024 Held at NCTC, Pabbi CNS Visits Coastal Belt of Sindh and Coastal Areas of Balochistan to Oversee the Conduct of Exercise Seaspark-2024 Keel Laying Ceremony of the Second HANGOR Class Submarine Held at Karachi Shipyard and Engineering Works Chinese Ambassador Calls on Chief of the Air Staff Pakistan Navy Demonstrates Combat Readiness with Live Missile Firing Exercise in the North Arabian Sea PAF's Jf-17 Thunder Block-III Fighter Jet Participates in World Defense Air Show-2024 A Day of Celebration and Global Solidarity: Pakistan Day Parade 2024 Gaza: A Tragedy Beyond Words Better Late than Never... Escalating Tensions: India's Violations of the Indus Waters Treaty Preserving Pakistan Pakistan Day Parade-2024: A Celebration of National Unity and Strength Demolition of Muslim Properties in India: A Weapon of Choice and State Policy Sustainable Energy Transition: Strategies for Pakistan’s Shift towards Renewable Resources and Energy Efficiency The Impact of Climate Change on Global Health: Building Resilient Health Systems SIFC, From Vision to Reality (Part III) Emerging from the Depths: The Pakistan Army Dedicated to Promoting Tolerance and Diversity: Pakistan Army, in Collaboration with the University of Peshawar, Hosts a Successful Grand Peace Fair Pak-Saudi On Job Training 2024 CJCSC Addresses SCO Military Medical Seminar 2024 on Challenges in Military Medicines Loyalty, Honor, Duty: The Pivotal Role of Pakistan Armed Forces in Upholding Peace and Security From Darkness to Light–One Year On: Contemplating May 9, 2023 to May 9, 2024 Beyond the Smoke and Mirrors Global Perspectives on Content Regulation: Examining Network Enforcement Act and Disinformation Laws The Issue of Palestine: A Historical, Religious, and Humanitarian Perspective Modi’s Guarantee and Hindutva Incorporated Divide and Conquer: The Dangerous Surge of Anti-Muslim Rhetoric in Indian Politics India's Hybrid Warfare in Kashmir India: Where the Price of Protest is Death! Pakistani Peacekeepers and the International Peacekeeping Day Empowering Pakistan: Navigating the Path to Sustainable Energy Autarky Overpopulation: Navigating Challenges and Charting Solutions for Pakistan Pakistan and Saudi Arabia Friendship: Dawn of a New Era SIFC, From Vision to Reality (Part IV) A Tale of Two Sultans: Brigadier Sultan Ahmed, SJ & Bar (Part II) In the Footsteps of Valor: A Journey through Peshawar Garrison Pakistan Military Academy Passing Out Parade-2024 CGS Turkish Armed Forces Calls on COAS Green Pakistan Initiative Conference Highlights National Commitment to Agricultural Innovation and Economic Growth Commander Turkish Land Forces Calls on COAS Minister of Foreign Affairs, KSA, Calls on COAS Assistant Minister of Defense, KSA, Calls on COAS PAF Academy Asghar Khan Hosts Prestigious Graduation Ceremony for Aviation Cadets Faculty and Students from Muzaffargarh Government Post Graduate College Visit Multan Garrison SIFC's First Year: Transforming Pakistan's Investment Landscape SIFC’s First Birthday SIFC Building an Investor SIFC, From Vision to Reality (Part V) : Driving Growth in Industry, Tourism, and Privatization SIFC and Pakistan’s Economic Landscape: A Year in Review Chinas Transition from Industry 3.0 to 4.0 Social Media in Pakistan: Balancing Risks and Governance for National Security Indian Ambitious “Make in India” Approach for Defense Production: An Appraisal India s Bold Shift: Extraterritorial Killings and Regional Instability as the New Normal Charting a Path Towards Water Sustainability: Pakistan Comparative Analysis of IQ, EQ, SQ and AQ Harboring Opportunities: The Socioeconomic Benefits of Gwadar Port Development for Pakistan and the Region From Gridlock to Green Lanes: OLMRTS Drive Progress Evolution of Multan: A Journey Through the Past, Present, and Future Empowering Tomorrow Embracing Tradition: Welcoming the 17th Entry to Military College Sui Balochistan Champions of the Desert: Balochistan Sheikha Fatima Bint Mubarak Girls Cadet College Turbat Hosts First Passing-out Parade Secretary General of Defense and National Armaments, Italy, Calls on CJCSC U.S. CENTCOM Commander Calls on COAS Chief of Defense Forces Australia Calls on COAS Turkish Foreign Minister Visits COAS COAS and CGS UK Army’s Address at 6th Pakistan-UK Regional Stabilization Conference GHQ Investiture Ceremony Held at General Headquarters COAS Extends Condolence to Iran Following Helicopter Crash That Claimed Top Officials CNS visits PLA (Navy) Headquarters China CNS Attends 19th Western Pacific Naval Symposium CNS Attends the Launching Ceremony of 1st HANGOR Class Submarine CAS Calls on General Secretary of MOD and Commander of Iraqi Air Force Commander Southern Command and 2 Corps Visits Khairpur Tamewali Pakistan-U.S. Navy Bilateral Exercise Inspired Union 2024 Pakistan Navy's Humanitarian Mission in Balochistan's Flood-ravaged Villages The Heat is On: How Pakistan is Battling the Dire Consequences of Climate Change Solid Waste Management in Pakistan: Promotion of Sustainable Circular Economy Revolutionizing Flood Risk Management in Pakistan: Harnessing the Power of River Indus Assumptions Vs. Realities: Demystifying Pakistan‘s Defense Budget Unresolved Turmoil, The Gaza Conflict and Israel‘s Strategic Quagmire Post Shangri-La Dialogue: Prospects for Regional Security and Stability Optimizing the Benefits of CPEC 2.0 Sagadat Nurmagambetov: An Example of Persistence, Courage, and Selfless Devotion to the Motherland From Digital Resistance to Pro-Palestinian Encampment SIFC: Catalyst for Foreign Investment Driving Pakistan‘s Economic Transformation Charting a Green Future: How SIFC is Leading Pakistan‘s Green Revolution Digital Terrorism: Implications for Pakistan‘s National Security and Policy Tich‘ Cowan – The Fighting Admiral Leepa Valley: Where Nature Meets Patriotism RUMANZA: Transforming Pakistan‘s Golfing Landscape with World-Class Excellence Inside Okara Garrison: Students Witness Pakistan Army‘s Training and Tradition Prime Minister Pays Tribute at Sepoy Haroon William‘s Funeral Service CJCSC Visits Turkiye Chief of Defense Forces Australia Calls on CJCSC COAS Visits the LOC in the Haji Pir Sector Chief of Royal Malaysian Navy Calls on CNS Royal Saudi Naval Forces Delegation Visits Pakistan CAS Visits Command and Staff College Quetta Commander Multan Corps Reviews Troops’ Watermanship Training in Okara Rescue at Sea: Pakistan Navy Saves 8 Iranian Fishermen Amid Vessel Fire
Advertisements

Hilal English

Indian Pharmaceutical Industry: A Dangerous Savior

October 2023

This article delves into the grave concerns surrounding the Indian pharma sector, which has resulted in numerous casualties and severe health hazards to its consumers, underlining the urgency for stringent regulatory measures, reassessment of its practices, and a mandatory global crackdown.



The Indian pharmaceutical industry has witnessed a remarkable surge in growth, becoming a crucial player in meeting global healthcare demands. Presently, it produces 20 percent of the world's generic drugs and 50 percent of global vaccines. India claims to be the mantle of the "Pharmacy of the World." As per the Indian government's official statistics, the pharma industry in India has achieved exponential growth, from zero to 13 percent, and is expected to grow to USD 130 billion by 2030. 
To the contrary, the World Health Organization (WHO) and the United States Food and Drug Administration (FDA) have issued several warnings and product alerts to Indian manufactured substandard medicines after discovering an overwhelming number of criminal complaints; illegal rebranding, export of counterfeit lifesaving drugs, and adulterated medicines with life-threatening levels of toxins. 
This article delves into the grave concerns surrounding the Indian pharma sector, which has resulted in numerous casualties and severe health hazards to its consumers, underlining the urgency for stringent regulatory measures, reassessment of its practices, and a mandatory global crackdown.
Ranbaxy Laboratories Scandal
One of the most notorious scandals in the Indian pharma industry involved Ranbaxy Laboratories, leading pharmaceutical companies until 2014. In 2004, the FDA and European drug regulators found adulteration of drugs at several of its facilities in India and blocked imports of medicines from Ranbaxy. 


In October 2016, two Indian pharmaceutical companies were charged under the Indian Drugs and Cosmetics Act for exporting counterfeit diabetes drugs.


The violations included data manipulation, inadequate testing procedures, and false statements made to the FDA. Ranbaxy had to pay hefty fines and faced legal consequences, tarnishing its reputation and casting a shadow over the industry's overall credibility. Ironically, the Indian government responded not with regulatory reform but trumpeted conspiracy theories and “vested interests” working against India.
Notably, in 2008, the U.S. blocked Ranbaxy imports from India for the third time.1 Eventually, in 2013, Ranbaxy Laboratories Ltd. pleaded guilty to U.S. federal criminal charges and agreed to pay USD 500 million for selling adulterated generic drugs, fabricating data, and committing fraud.2 Hence, such repeated offenses committed by Ranbaxy Laboratories resulted in its ban by FDA in February 2014.
Corruption in Central Drugs Standard Control Organization
The Central Drugs Standard Control Organization (CDSCO) is the primary regulatory body for medical devices in India and is equivalent to U.S. FDA. The agency is responsible for ensuring the safety, quality, and efficacy standards of Indian medical devices. In 2012, the Indian Ministry of Health and Family Welfare scrutinized the performance of CDSCO and presented a report before the parliament. This report states that CDSCO was found guilty of colluding with pharmaceutical firms by issuing them illegal licenses for their under-tested and poorly manufactured products. The report also found nexus between drug companies and CDSCO experts. The committee also described CDSCO as an understaffed organization with insufficient resources to carry out its duties.3
Export of Counterfeit Diabetes Drugs
In October 2016, two Indian pharmaceutical companies were charged under the Indian Drugs and Cosmetics Act for exporting counterfeit diabetes drugs.4 Wanbury Ltd, a Mumbai-based Active Pharmaceutical Ingredients (API) manufacturing company, was caught by the Maharashtra Food and Drug Administration for illegally exporting metformin hydrochloride, a diabetic drug, to Mexico, Brazil, Bangladesh, and Pakistan. After inspection, it was revealed that Wanbury had to export orders of 650 metric tons per month, but could manufacture only 300 metric tons. Therefore, to overcome the drug shortage, Wanbury outsourced the manufacturing of diabetes medicine to an illegal company named Pharmaceutical Products of India Ltd (PPIL). The Wanbury then rebranded and exported the drugs it received from PPIL without testing their authenticity and quality, thereby risking the lives of millions across the globe. The illegal activity had been going on for several years. 


After identifying Made in India toxic medicines found in Lebanon and Yemen, the WHO issued a medical product alert warning the consumer, “Please DO NOT use them”


Fake COVID Vaccination Drive 
Indian pharmaceutical malpractices did not stop during the deadly COVID-19 pandemic when every country was fighting against an unseen enemy as one force. The World Health Organization flagged the danger of a fake COVID-19 vaccination drive in India. An important example is Kolkata, where Mimi Chakraborty, a member of parliament, was administered fake versions of Covishield, an Indian version of the AstraZeneca vaccine, and 500 people from the general public.5
A Fifty-Year Track Record of Tainted Medicines 
In their 2022 book titled, Truth Pill, public health activist Dinesh S. Thakur and lawyer Prashant Reddy shed light on a myriad of criminal complaints against the Indian pharmaceutical industry, exposing concerning issues such as the lack of regulatory accountability and non-compliance with scientific methodology. The book underscores the grave implications for consumers of essential lifesaving medicines manufactured in India. Furthermore, the book delves into the alarming revelation of drug contamination with DEG (diethylene glycol) and EG (Ethylene Glycol) chemicals commonly used in polymer production and antifreeze, ubiquitous in Indian manufactured medicines as agents of death since 1972. 
The authors provide compelling evidence by citing five significant DEG poisoning cases that have occurred over the years, drawing attention to the severity of the issue.
The first was reported in 1972 in Madras, now called Chennai, which resulted in the deaths of 15 children. The second case was reported in 1986, killing 14 patients in Mumbai after they consumed Glycerin that had been adulterated with DEG. Bihar was the third region where 11 patients lost their lives in 1988. In the same year, 33 children were killed in Gurgaon, a district neighboring Delhi. Lastly, 11 poor children of Indian Illegally Occupied Jammu and Kashmir (IIOJK) lost the battle of their lives in 2019.6
Recently in February 2020, the deaths of 17 children hailing from IIOJK were brought to the world's attention. Like the previous examples, these children, too, lost their lives due to the contaminated cough syrup made by an Indian company called Digital Vision, which reiterated the long history of criminal complaints against Indian pharmaceutical companies. 
International Cases Linked Criminal Complaints of Made-in-India Medicines
Deaths in Gambia. In October 2022, an Indian-based company named Maiden Pharmaceuticals made cough syrup that caused acute kidney injuries and the deaths of 69 children in Gambia.7 A medical product alert issued by the WHO stated that excessive levels of DEG and EG had been found in the four products produced that were sold to the Gambia by India’s Maiden Pharmaceuticals.8


The landscape of India's pharmaceutical industry stands tainted by corruption and marred by scandalous practices that have resulted in the loss of numerous lives, abnormalities, and organ failure to consumers of Indian manufactured medicines, both in India and globally.


It is worth mentioning that Reuters, in a worrisome revelation, exposed Maiden Pharmaceuticals' collusion to cover its criminal act through corruption. As per Reuter's June 2023 report, Maiden Pharmaceuticals, linked to the massacre of 96 children in Gambia, bribed USD 605,419 to a pharmaceutical regulator for switching samples before being tested by an Indian Government laboratory inquiry.9 
Deaths in Uzbekistan. On December 23, a medicinal syrup manufactured by Indian drug manufacturer Marion Biotech Pvt. Ltd. was also linked to the deaths of 18 children in Samarkand as the syrup contained toxic levels of DEG. Uzbekistan’s Ministry of Health stated that 18 out of 21 children who took the Doc-1 Max syrup while suffering from an acute respiratory disease died after consuming it.10
Contaminated Cancer Drugs in Lebanon and Yemen. On December 27, 2022, the WHO warned that contaminated batches of Indian-manufactured cancer medicines containing life-threatening levels of toxic bacteria were circulating in Lebanon and Yemen. After identifying Made in India toxic medicines found in Lebanon and Yemen, the WHO issued a medical product alert warning the consumer, “Please DO NOT use them.”11
Ingress of Misbranded/Illegal Pharma Companies. As per the Telegraph, in October and November 2022, over five percent of the 2,767 drugs and medical devices tested by the Indian government's regulator were found to be counterfeit, substandard, adulterated, or misbranded.  Moreover, over 80 Indian drug manufacturers who failed quality testing exported their medicines abroad, including two firms to the United Kingdom.
Liberia and Nigeria. On June 14, 2023, Bloomberg revealed that health officials from Liberia and Nigeria confirmed that 250 cartons of children's paracetamol syrup manufactured in India were seized due to toxic DEG and EG.13
Marshall Islands and Micronesia. On April 25, 2023, the WHO issued a Medical Product Alert after identifying Indian-manufactured contaminated syrup found in the WHO region of the Western Pacific, Marshall Islands, and Micronesia. As per the WHO statement, the analysis of Australian-based medicines quality control laboratories, the Therapeutic Goods Administration (TGA) “unacceptable amounts” of  DEG and EG in Indian manufactured cough syrups.14
Made-in-India Contaminated Eye Drops Blinded and Killed Americans. In May 2022, the Indian manufacturer of eye drops, Global Pharma, killed at least three U.S. citizens and blinded many patients.15  The FDA published a report after an 11-day inspection of  Global Pharma's plant in Chennai in 2023.16 The report observed several violations related to sterilization and hygiene and compromised safety norms in the facility in India.
In conclusion, the landscape of India's pharmaceutical industry stands tainted by corruption and marred by scandalous practices that have resulted in the loss of numerous lives, abnormalities, and organ failure to consumers of Indian manufactured medicines, both in India and globally. The gravity of the situation demands urgent global scrutiny and collaborative action. The proliferation of immoral and unlawful malpractices within the industry has brought to light the need for comprehensive regulatory reforms and stricter enforcement of ethical standards. The lack of legal power and inability to conduct surprise inspections or issue subpoenas hampers effective policing, further exacerbating the issue. The devastating impact of unscrupulous practices within India's pharmaceutical sector cannot be understated. The global community must join hands in urging stringent measures to hold those responsible for endangering lives through substandard medications.


E-mail: [email protected]


1.      Katie Thomas, U.S. Bans Import of Generic Drugs From Indian Plant, The NYT, September 16, 2013. https://www.nytimes.com/2013/09/17/business/us-bans-import-of-ranbaxy-drug-made-in-india.html.
2.      Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, cGMP Violations and False Statements to the FDA, May 13, 2013 https://www.justice.gov/opa/pr/generic-drug-manufacturer-ranbaxy-pleads-guilty-and-agrees-pay-500-million-resolve-false.
3.      Gayathri Vaidyanathan, Failings exposed at India’s drug regulator, May 18,2012 https://www.nature.com/articles/nature.2012.10668.
4.      Katrina Megget, October 12, 2016, India pharma firms caught for exporting counterfeit drugs, https://www.securingindustry.com/pharmaceuticals/india-pharma-firms-caught-for-exporting-counterfeit-drugs/s40/a2976/.
5.      Covishield: WHO flags fake jabs in India, Africa, August 18, 2021 https://www.bbc.com/news/world-asia-india-58253488.
6.      The Truth Pill: The Myth of Drug Regulation in India, https://www.google.com.pk/books/edition/The_Truth_Pill/BhCMEAAAQBAJ?hl=en&gbpv=1.
7.      Mike Ives, Here’s What to Know About the Cough Syrup Scandal, October 21, 2022, The NYT, https://www.nytimes.com/2022/10/21/world/asia/cough-syrup-india-indonesia.html.
8.      WHO alert over India-made cough syrups after deaths in The Gambia, https://www.bbc.com/news/world-africa-63150950.
9.      Krishna N. Das, Exclusive: India probes bribery claim in toxic syrup tests, June 14, 2023, https://www.reuters.com/world/india/india-probes-bribery-claim-toxic-syrup-tests-2023-06-13/.
10.    Uzbekistan says 18 children die after consuming India-made syrup, December 28, 2022 https://www.aljazeera.com/news/2022/12/28/uzbekistan-says-18-children-die-after-consuming-india-made-syrup.
11.    Medical Product Alert N°8/2022: Substandard (contaminated) METHOTREX 50mg, December 27, 2023 https://www.who.int/news/item/27-12-2022-medical-product-alert-n-8-2022-substandard-(contaminated)-methotrexate.
12.    Joe Wallen, Alert over cancer drug containing life-threatening bacteria, March 28, 2023 https://www.telegraph.co.uk/global-health/science-and-disease/alert-cancer-drug-containing-life-threatening-bacteria/.
13.    Festus Poquie and Zachary R. Mider, Liberia Is Latest Nation to Find Tainted Medicine from India, June 14, 2023, Bloomberg, https://www.bloomberg.com/news/articles/2023-06-14/liberia-is-latest-country-to-find-tainted-made-in-india-medicine#xj4y7vzkg.
14.    Substandard (contaminated) syrup medicines identified in WHO Region of the Western Pacific, April 25, 2023, WHO, https://www.who.int/news/item/25-04-2023-medical-product-alert-n-4-2023--substandard-(contaminated)-syrup-medicines.
 15.   Global Pharma: FDA says India firm linked to US eye drop deaths broke safety norms, April 4, 2023, BBC, https://www.bbc.com/news/world-asia-india-65171851. 
16.    FDA Inspection Report, FDA, https://www.fda.gov/media/166739/download.